New breathing method may protect preemie lungs

NCT ID NCT03736707

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special breathing machine called high-frequency oscillation ventilation (HFOV) works better than standard mechanical ventilation for very premature babies (born at 24 to 31 weeks) who have acute respiratory distress syndrome (ARDS). The goal is to see if HFOV can lower the chance of developing bronchopulmonary dysplasia (BPD), a chronic lung disease common in preemies. About 400 babies will be randomly assigned to one of the two breathing methods, and researchers will track lung health and other outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
High-frequency oscillation ventilation (HFOV) device
What this could lead to
If this works, it could show that HFOV reduces lung damage and bronchopulmonary dysplasia in very preterm babies compared to standard ventilation.
What could go wrong
This is an early-stage trial with 400 infants, and results may not apply to all preterm babies. HFOV also carries risks like air leaks or bleeding in the brain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Chongqing Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, 400042, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.